Re-Validation of the COmprehensive Score for Financial Toxicity (COST): Assessing the Scale’s Utility in Chronic Disease Populations

OBJECTIVE: To report the psychometric properties of the COmprehensive Score for financial Toxicity (COST) patient-reported outcome measure (PROM), an 11-item scale previously validated among patients diagnosed with cancer and receiving chemotherapy. METHODS: Data come from a cross-sectional survey (...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavela, G, Fifolt, M, Tison, SE, Allison, M, Burton, BS, Ford, EW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669122/
https://www.ncbi.nlm.nih.gov/pubmed/34916802
http://dx.doi.org/10.1177/11786329211057352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669122/
https://www.ncbi.nlm.nih.gov/pubmed/34916802
http://dx.doi.org/10.1177/11786329211057352

Ejemplares similares